Skip to main content
padlock icon - secure page this page is secure

Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management

Buy Article:

$68.00 + tax (Refund Policy)

Intractable and untreatable pain from cancer remains a challenge for both patients and clinicians. The pain may be related to the disease itself or the consequences of treatment, such as surgery, chemotherapy or radiation therapy. Cancer pain is intense and has a major impact on patient's quality of life and survival. A significant number of patients receiving analgesic therapy with opioids report persisting pain of a higher intensity than the pain in those who were not on this class of drugs. The pathophysiology of pain in cancer patients is complex and remains poorly understood. Several research groups have studied and demonstrated that cancer and cancer-related symptoms may have an underlying problem of membrane hyper-excitability due to over-presentation of sodium channels and glutamate build-up or over-stimulation of glutamate/N-methyl-D-aspartate (NMDA)/α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) system in cancer cells and the body.

Dimethyl sulfoxide (DMSO) is a naturally derived, inexpensive, non-toxic solvent and pharmaceutical agent that has been demonstrated to have numerous health enhancing and therapeutic benefits. In the present article, we provide the scientific evidence and substantiate possible application of DMSO as a well-tolerated excitatory modulator in the management of cancer pain.



No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Cancer pain; Dimethyl Sulfoxide (DMSO); Dimethyl sulfoxide; Dimethyl sulfoxide (DMSO); N-methyl-D-aspartate (NMDA); Sodium channel (SC); amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA); analgesic therapy; antiarrhythmic; antiepileptic; cachexia; calcium influx; cancer; cell membrane hyperexcitability; chemotherapy; cryoprotectant; edema; hemoglobinuria; hepatotoxicity; hyperalgesia; hyperexcitability; ketamine; metastases; nephrotoxicity; neuropathic pain; nociceptive; opioids; pain; psychomimetic effects; radiation therapy; raspberries; sodium channel blocker; sodium channels; sodium channels (SC); spinal nerve ligation, spinal nerve transection; surgery; tetrodotoxin; traumatic brain injury

Document Type: Research Article

Publication date: September 1, 2010

More about this publication?
  • Inflammation & Allergy - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in inflammation and allergy e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in inflammation and allergy. As the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continues to grow, this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more